CIK 0000014272
- Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 220790350
- Phone
- +1 609-252-4621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-31 | Emmens Matthew Director | Grant or award · Deferred Share Units | +574.21 | $63.13 | $36K | 26,998.92 |
| 2021-03-31 | Haller Julia A Director | Grant or award · Deferred Share Units | +514.81 | $63.13 | $33K | 9,689.56 |
| 2021-03-31 | Paliwal Dinesh C Director | Grant or award · Deferred Share Units | +613.81 | $63.13 | $39K | 40,501.11 |
| 2021-03-31 | Price Paula A Director | Grant or award · Deferred Share Units | +113.85 | $63.13 | $7K | 4,649.27 |
| 2021-03-31 | Rice Derica W Director | Grant or award · Deferred Share Units | +455.41 | $63.13 | $29K | 5,454.97 |
Page 73 of 73 · 1,445 trades